Treatment with K975, a small molecular inhibitor of the YAP/TAZ-TEAD interaction, dramatically suppressed EMT-derived GC metastasis and displayed an apparent synergistic effect when in combination with a MEK1/2 inhibitor[93]. Here, YAP1 is linked to gastric cancer.